Physician profile
Jan M Johnson
NPI 1326193632
$1,304.81
in general payments reported to CMS, 2019-2025
16 companies · $423 in 2025
The $423 reported for 2025 was more than what 90% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $34.32 · 2021: $150 · 2022: $191 · 2023: $157 · 2024: $245 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $333.01 | 2020-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Sanofi Pasteur INC. | $214.06 | 2019-2025 | |
| Alk-Abello, INC | $111.82 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $79.78 | 2024-2025 | |
| Glaxosmithkline, LLC. | $78.90 | 2019-2025 | Bexsero, Penmenvy |
| Pfizer INC. | $74.86 | 2022-2024 | |
| Cranial Technologies, INC | $64.44 | 2019-2025 | Doc Band |
| Astrazeneca Pharmaceuticals LP | $63.44 | 2023-2024 | Flumist Quadrivalent |
| Corium, LLC | $60.80 | 2021-2022 | |
| Seqirus USA INC | $49.81 | 2023 | Flucelvax Quadrivalent |
| Kaleo, INC. | $46.27 | 2020-2021 | |
| Abbvie INC. | $39.83 | 2019-2022 | |
| Dermira, INC. | $37.97 | 2019 | |
| Alexion Pharmaceuticals, INC. | $22.42 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.15 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.